SSSharmin Sultana

Sharmin Sultana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sharmin Sultana has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Abdullah Omar Nasif

    Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh

    1 shared publication
  • Afzalun Nessa

    Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh

    1 shared publication
  • Afzalun Nessa

    Professor, Department of Virology, Bangladesh Medical University

    1 shared publication
  • Amirul Huda Bhuiyan

    Department of Virology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, Bangladesh

    1 shared publication
  • Ashrafun Nessa

    Department of Gynecological oncology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

    1 shared publication
  • Asish Kumar Ghosh

    Department of Virology, Dhaka Medical College Hospital, Dhaka 1000, Bangladesh

    1 shared publication

Latest Publications

  • Open Access

    Liquid Biopsy–Based Profiling of TP53 Gene Hotspot Mutations in HBV‐Induced Chronic Liver Disease and Hepatocellular Carcinoma Patients: A Study From Bangladesh

    by Sabinur Akter, Sharmin Sultana, Md. Zulqarnine Ibne Noman, Farzana Laila, Afzalun Nessa

    Background: The tumor protein ( TP53 ) gene is a common driver gene for somatic mutations in hepatocellular carcinoma(HCC), and detection may provide insight into evaluating disease progression. Circulating cell‐free DNA (cfDNA) from liquid biopsy has emerged as a promising noninvasive biopsy material for identifying potential genetic alterations. This study explored the mutational signature of the TP53 gene in Hepatitis B virus (HBV)–infected chronic liver disease (CLD) and HCC patients from cfDNA. Method: A total of 80 participants: 30 HCC, 30 CLD, and 20 healthy controls were included in this cross‐sectional study. cfDNA was extracted from aseptically collected peripheral venous blood. TP53 (R249S) gene was amplified using selected primers via conventional PCR and visualized on a 2% agarose gel electrophoresis. Amplified products underwent Sanger sequencing; mutational analysis was done using MEGA11 software compared with the reference sequence. Result: TP53 hotspot mutations were found in 23.3% (7/30) of HCC patients. Mutational frequencies were detected: 13.3% (4/30) at position 746G > A (R249S), 6.7% (2/30) at 747G > A (R249S), and 3.3% (1/30) at 735C > T (G245S). Among CLD patients, a single hotspot mutation (3.3%) was detected at position 744G > A/T(R248Q/W). However, no hotspot mutation was detected in healthy controls. All HCC patients with mutations (7/7, 100%) had elevated ALT, AST, serum bilirubin, and AFP levels, and in the unmutated (wild) group, these were 69.6%, 47.8%, 30.4%, and 60.9%, respectively. The mean AST and AFP levels were significantly higher in mutated patients compared with the wild group. Conclusion: Detection of TP53 gene mutations along with biochemical markers in the management of HCC is evident, and it may play an important role in targeted therapy and personalized treatment plans.

  • Open Access

    Patterns of Different Cervical Cytokine Expression in High-Risk Human Papillomavirus–Infected Patients With Cervical Cancer and Its Precancerous Lesions

    by Shamoli Saha, Sharmin Sultana, Raad Rahmat, Tahmina Akther, Ashrafun Nessa, Munira Jahan

    Background: Cervical cancer is the second most common cancer in Bangladesh and is primarily caused by persistent high-risk human papillomavirus (HR-HPV) infection. Several risk factors, including immunological, genetic, environmental, and viral factors, may contribute to the development of cervical cancer. Moreover, a disruption in an otherwise delicate balance between immune response and cytokine production may lead to diseased states. Henceforth, this study aimed to determine and compare selected cytokines, including interleukin-6 (IL-6), interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ), interleukin-10 (IL-10), GM-CSF, interleukin-8 (IL-8), and MCP-1 among HR-HPV-infected patients with cervical cancer, precancer individuals, and healthy participants to test the propensity of these cytokines to serve as predictive biomarkers for the detection of cervical cancer during its early stages. Methods: A cross-sectional study was conducted on female patients visiting two referral hospitals in Bangladesh from September to November 2022. Among them, 80 women were enrolled in the study as patients with cervical cancer and precancerous lesions along with HPV DNA–negative healthy individuals. The selected cytokines in the cervical swab were estimated by flow cytometry. Result: Cervical cancer and precancer were primarily detected in patients aged above 40 years (73.3% and 46.7% of the patients in the respective groups). Other significant risk factors, including poor educational, socioeconomic status and nutritional conditions, age of first coitus, multiparity, and tobacco and betel nut consumption, were found significant for the development of cervical cancer and precancer ( P < .05). The levels of IL-6, IL-1β, IL-10, IL-8, and MCP-1 were substantially elevated in patients with cancer than in patients with precancer and healthy individuals ( P < .001). Moreover, the levels of IL-6, IL-1β, IL-10, and IL-8 were also significantly increased in patients with precancer than in healthy individuals ( P < .05). Conclusions: Thus, IL-6, IL-1β, IL-10, IL-8, and MCP-1 can be used as potential biomarkers for diagnostic and prognostic purposes in HPV-induced cervical cancer and precancer.


  • Open Access

    Challenges in the establishment of a biosafety testing laboratory for COVID-19 in Bangladesh

    by Sm Rashed Ul Islam, Tahmina Akther, Sharmin Sultana, Paroma Deb, Asish Kumar Ghosh, Abdullah Omar Nasif, Amirul Huda Bhuiyan, Munira Jahan, Afzalun Nessa, Saif Ullah Munshi, et al.

    At the beginning of the coronavirus disease 2019 (COVID-19) pandemic in Bangladesh, there was a scarcity of ideal biocontainment facilities to detect the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a risk group of 3 organisms. Molecular detection of SARS-CoV-2 must be performed in a BSL-2 laboratory with BSL-3-equivalent infection prevention and control practices. Establishing these facilities within a short timeframe proved to be an enormous challenge, including locating a remote space distant from the university campus to establish a laboratory, motivating the laboratory staff to work with a novel pathogen without any prior experience, allocation of funds for essential equipment and accessories, and arrangement of a safe waste management system for environmental hazard reduction. This report also highlights several limitations, such as the facility's architectural design that did not follow the biosafety guidelines, lack of continuous flow of funds, and an inadequate number of laboratory personnel. This article describes various efforts taken to overcome the challenges during the establishment of this facility that may be adopted to create similar facilities in other regions of the country. Establishing a BSL-2 laboratory with BSL-3-equivalent infection prevention and control practices will aid in the early detection of a large number of cases, thereby isolating persons with COVID-19, limiting the transmission of SARS-CoV-2, and promoting a robust public health response to contain the pandemic.


  • Open Access

    Sweeping Membrane at 40 Weeks Initiation of Normal Labour Induction: A Randomized Controlled Trial

    by H Akthar, S Sultana, D Begum, Z Nahar

    One hundred twenty women at 40 weeks pregnancy with singleton foetus in cephalic presentation and intact membrane were randomly assigned to receive membrane sweeping or no membrane sweeping. The aim of this study was to determine the benefit of membrane sweeping at initiation of labour induction in conjunction with other methods of labour induction. After sweeping Bishop Score was done and in sweeping group, oxytocin infusion or misoprostol was administered 6 hours later. In control group, oxytocic agent was administered after vaginal examination. Among one hundred twenty women (60 sweep and 60 non-sweep) show that swept women had higher spontaneous vaginal delivery rate (83% compared with 60%). Shorter induction to delivery interval (12 hours compared with 19 hours), fewer that required oxytocin use (15% compared with 50%), shorter duration of oxytocin infusion (2 hours compared with 4 hours). Membrane sweeping at initiation of lab our induction increased the spontaneous vaginal delivery rate, reduced oxytotic drug use, shortened induction to delivery interval. TAJ 2009; 22(1): 204-206